CG Oncology, Inc. Common stock (NASDAQ: CGON) last traded at $79.81, up 2.83% on the session. The quote above updates while this page is open; the figures below are drawn from CG Oncology, Inc. Common stock’s own filings and are restated only when a new one is published.
CG Oncology, Inc. Common stock trades on NASDAQ under the ticker CGON. Its market capitalisation is $7.07 billion.
Valuation measures for CG Oncology, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.07B |
|---|---|
| Enterprise value | $7.11B |
| Price / sales | 1135.90 |
| Price / book | 6.87 |
| Beta | 1.16 |
Trailing-twelve-month figures tagged in CG Oncology, Inc. Common stock's XBRL filings with the SEC.
| Revenue (TTM) | $6.23M |
|---|---|
| Net income (TTM) | -$224.38M |
| EPS (TTM) | -$2.70 |
| Operating margin | -4056.18% |
| Return on equity | -21.80% |
| Cash | $19.64M |
Range and volume for CGON over the past 52 weeks.
| 52-week high | $80.97 |
|---|---|
| 52-week low | $25.25 |
| Volume | 627.4K |
| Average volume | 1.01M |
| Previous close | $77.61 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.